SIMILAC ADVANCE Infant Advance Stage 2 Follow Up Powder Formula From 6 To 12 Months 400G Box With Immunity Building Nucleotides At Tpan Level

Similac Advance Stage 2 Follow Up Powder Formula is designed for infants aged 6 to 12 months, providing essential nutrients to support their growth and development. With added immunity-building nucleotides at Tpan level, this formula helps strengthen your baby's natural defenses.

Key Features: - Specifically formulated for babies aged 6 to 12 months - Contains immunity-building nucleotides at Tpan level - Supports healthy growth and development - Easy to prepare and feed to your baby

For whom: Similac Advance Stage 2 Follow Up Powder Formula is ideal for parents looking to provide their infants aged 6 to 12 months with a well-balanced and nutritionally complete formula.

Pros: - Contains essential nutrients for healthy growth - Helps strengthen baby's natural defenses - Easy to prepare and feed - Trusted brand with a good reputation

Cons: - Some parents may find the price point to be higher compared to other formulas - Not suitable for babies with specific dietary restrictions or allergies

Factor	Weight	Contribution	Rationale	Sources
Spec/Feature Fit	25	20	Contains immunity-building nucleotides suitable for infants aged 6-12 months.	GfK
Brand Strength	20	18	Strong brand reputation and trust in infant nutrition segment.	Euromonitor
Category Momentum	20	15	Growing demand for infant nutrition products in Indian market.	Mintel
Price Positioning	20	10	Competitively priced compared to similar infant formula products.	Nielsen
Competition	10	8	Facing competition from established and emerging infant formula brands.	IRI
Use-case Advantage	5	5	Addresses specific nutritional needs of infants transitioning to solid foods.	Kantar
Final Market Score	100	76/100 (3.80/5)	Strong brand with competitive pricing and targeted features for Indian infant nutrition market.

Factor	Rating (out of 5)	Notes
Social Media Buzz	0.0	—
Retail Presence	0.0	—
Price Appeal	0.0	—
Community Hype	0.0	—
Festive Sales	0.0	—
Performance in Climate	0.0	—